WO2000033667A3 - Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes - Google Patents

Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes Download PDF

Info

Publication number
WO2000033667A3
WO2000033667A3 PCT/US1999/029440 US9929440W WO0033667A3 WO 2000033667 A3 WO2000033667 A3 WO 2000033667A3 US 9929440 W US9929440 W US 9929440W WO 0033667 A3 WO0033667 A3 WO 0033667A3
Authority
WO
WIPO (PCT)
Prior art keywords
bioflavonoids
anthocyanins
cherries
antioxidants
phenol compounds
Prior art date
Application number
PCT/US1999/029440
Other languages
English (en)
Other versions
WO2000033667A2 (fr
Inventor
Muraleedharan G Nair
Haibo Wang
Gale M Strasburg
Alden M Booren
James I Gray
Original Assignee
Univ Michigan State
Muraleedharan G Nair
Haibo Wang
Gale M Strasburg
Alden M Booren
James I Gray
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/317,310 external-priority patent/US6423365B1/en
Priority claimed from US09/329,604 external-priority patent/US6150408A/en
Application filed by Univ Michigan State, Muraleedharan G Nair, Haibo Wang, Gale M Strasburg, Alden M Booren, James I Gray filed Critical Univ Michigan State
Priority to AU21754/00A priority Critical patent/AU2175400A/en
Priority to KR10-2001-7007239A priority patent/KR100441927B1/ko
Priority to JP2000586180A priority patent/JP2002531473A/ja
Publication of WO2000033667A2 publication Critical patent/WO2000033667A2/fr
Publication of WO2000033667A3 publication Critical patent/WO2000033667A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une technique présentant des bienfaits nutraceutiques ou phytoceutiques pour un mammifère, en particulier pour l'homme, et qui consiste à utiliser des dérivés de cerise. L'invention porte également sur une technique permettant d'inhiber l'oxydation dans une matière vivante biologique. Selon ces techniques, on utilise une composition d'anthocyanines, de bioflavonoïdes, de phénoliques ou de mélanges en résultant à base de cerises.
PCT/US1999/029440 1998-12-11 1999-12-10 Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes WO2000033667A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU21754/00A AU2175400A (en) 1998-12-11 1999-12-10 Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits
KR10-2001-7007239A KR100441927B1 (ko) 1998-12-11 1999-12-10 체리 단리물을 포함하는 뉴트라슈티칼 또는 파이토슈티칼의 잇점을 제공하는 배합물
JP2000586180A JP2002531473A (ja) 1998-12-11 1999-12-10 酸化防止剤の植物的又は栄養的利益を与えるサクランボ単離物の使用方法

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US11194598P 1998-12-11 1998-12-11
US60/111,945 1998-12-11
US12017899P 1999-02-16 1999-02-16
US60/120,178 1999-02-16
US09/317,310 US6423365B1 (en) 1998-12-11 1999-05-24 Method and compositions producing cherry derived products
US09/317,310 1999-05-24
US09/329,604 US6150408A (en) 1998-12-11 1999-06-10 Tart cherry compounds that have antioxidant activity and uses thereof
US09/329,604 1999-06-10
US34207699A 1999-06-28 1999-06-28
US09/342,076 1999-06-28

Publications (2)

Publication Number Publication Date
WO2000033667A2 WO2000033667A2 (fr) 2000-06-15
WO2000033667A3 true WO2000033667A3 (fr) 2000-08-31

Family

ID=27537321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029440 WO2000033667A2 (fr) 1998-12-11 1999-12-10 Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes

Country Status (5)

Country Link
JP (1) JP2002531473A (fr)
CN (1) CN100394916C (fr)
AU (1) AU2175400A (fr)
TW (1) TWI223982B (fr)
WO (1) WO2000033667A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269421C (zh) * 1998-12-11 2006-08-16 密执安州大学 生产源于浆果的产物的方法和组合物
EP1307212B1 (fr) * 2000-07-31 2007-03-28 World Resources Corporation Antioxydants derives de plantes
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
GB0127032D0 (en) 2001-11-09 2002-01-02 Medpalett Pharmaceuticals As Product
GB0316757D0 (en) * 2003-07-17 2003-08-20 Biochem Lab As Use
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
EP2108692A1 (fr) * 2008-04-11 2009-10-14 Brasseries Kronenbourg Procédé d'obtention d'extraits concentrés en polyphénols issus du procédé de brassage
JP2015051934A (ja) * 2013-09-05 2015-03-19 地方独立行政法人青森県産業技術センター 皮膚の酸化的ストレス抑制剤
CN112624928B (zh) * 2021-01-21 2023-03-17 黄河科技学院 一种抗凝血桃花有效成分及其应用
CN114990168B (zh) * 2021-08-24 2023-05-26 灶灶科技有限公司 酸樱桃发酵制得的具有良好保健功能的组合物及其在健康领域的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003146A1 (fr) * 1990-08-20 1992-03-05 Ohlenschlaeger Gerhard Melange de composes de glutathion et d'anthocyane actif en therapeutique
JPH06248267A (ja) * 1993-02-24 1994-09-06 S I I Techno Res:Yugen 新規抗酸化剤
JPH06271850A (ja) * 1993-03-23 1994-09-27 Nikken Food Kk 天然物を原料とした抗酸化剤およびその製造方法
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
DE19720767A1 (de) * 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003146A1 (fr) * 1990-08-20 1992-03-05 Ohlenschlaeger Gerhard Melange de composes de glutathion et d'anthocyane actif en therapeutique
JPH06248267A (ja) * 1993-02-24 1994-09-06 S I I Techno Res:Yugen 新規抗酸化剤
JPH06271850A (ja) * 1993-03-23 1994-09-27 Nikken Food Kk 天然物を原料とした抗酸化剤およびその製造方法
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
DE19720767A1 (de) * 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BÖHM H ET AL: "Flavonole, Flavone und Anthocyane als natürliche Antioxidantien der Nahrung und ihre mögliche Rolle bei der Prävention prevention chronischer Erkrankungen", ZEITSCHRIFT FÜR ERNÄHRUNGSWISSENSCHAFT, vol. 37, June 1998 (1998-06-01), pages 147 - 163, XP000886715 *
DATABASE DISSERTATION ABSTRACTS DIALOG FILE 35: 1998; WANG, HAIBO: "ANTIOXIDANT AND ANTI-INFLAMMATORY COMPOUNDS IN TART CHERRIES (ANTHOCYANINS, PHENOLICS, FLAVONOIDS, BALATON, MONTMORENCY)", XP002137469 *
DATABASE WPI Section Ch Week 199440, Derwent World Patents Index; Class B05, AN 1994-322419, XP002137672 *
DATABASE WPI Section Ch Week 199443, Derwent World Patents Index; Class B02, AN 1994-347353, XP002137671 *
DISSERTATION; MICHIGAN STATE UNIVERSITY; EAST LANSING, MI, USA, (1998) AVAIL UMI; ORDER NO. AAD99-22386 (157 pages) *
I MARINA HEINONEN ET AL: "Antioxidant activity of berry phenolics on human low density lipoprotein and liposome oxidation", J AGRIC FOOD CHEM, vol. 46, 1998, pages 4107 - 4112, XP000886697 *
TSUDA T ET AL: "Antioxidative activity of the anthocyanin pigments cyanidin 3-O-beta-D-glucoside and cyanidin", J AGRIC FOOD CHEM, vol. 42, 1994, pages 2407 - 2410, XP000474636 *
WANG H ET AL: "Quantification and characterization of anthocyanins in balalon tart cherries", J AGRIC FOOD CHEM, vol. 45, 1997, pages 2556 - 2560, XP000886708 *
WANG HONG: "Oxygen radical absorbing capacy of anthocyanins", J AGRIC FOOD CHEM, vol. 45, 1997, pages 304 - 309, XP000886698 *

Also Published As

Publication number Publication date
CN1334740A (zh) 2002-02-06
WO2000033667A2 (fr) 2000-06-15
JP2002531473A (ja) 2002-09-24
AU2175400A (en) 2000-06-26
CN100394916C (zh) 2008-06-18
TWI223982B (en) 2004-11-21

Similar Documents

Publication Publication Date Title
AU2001249967A1 (en) Composition and methods for tissue preservation
AU2002236527A1 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
MXPA01009415A (es) COMPOSICION DE ACIDO ASCORBICO Y METODO PARA TRATAMIENTO DE PIEL DAnADA O ENVEJECIDA.
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
WO2004026857A3 (fr) Methodes de preparation de cannabinoides a partir de matiere vegetale
AU3833900A (en) Device and method for the preservation of foods under vacuum
WO2000033667A3 (fr) Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
CA2371896A1 (fr) Procede permettant d'augmenter la teneur en flavonoides et en composants phenoliques dans des plantes
AU5336499A (en) Composition and method of treating disease with extract of (musaceas)
WO2000029002A3 (fr) Transplantation intra-uterine de cellules embryonnaires mesenchymateuses humaines
AUPR211400A0 (en) Material and method for treatment of timber
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
DE60006448D1 (de) Mercaptoalkohol-Verbindungen als als Geschmackstoffe
PL322310A1 (en) Substances extracted from dictyotales, method of obtaining and compositions containing them
NO972282D0 (no) Gjenstand for frossen sukkervare som inneholder inklusjoner, og fremgangsmåte for fremstilling av gjenstanden
ZA994493B (en) Process for the treatment of fruits and vegetables.
AU2002310982A1 (en) Method for the protective treatment of wood and derived timber products
AU2002246747A1 (en) Processes for making cryopreserved composite living constructs and products resulting therefrom
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
AU5559300A (en) Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms
AU2002245510A1 (en) Method and composition for embalming
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2002360583A1 (en) Method of isolating extract from the euphorbaciae obesa plant and methods for using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99816054.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1020017007239

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2000 586180

Country of ref document: JP

Kind code of ref document: A

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020017007239

Country of ref document: KR

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: 1020017007239

Country of ref document: KR